Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 561

1.

Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.

Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M; CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

Antimicrob Agents Chemother. 2014;58(3):1529-37. doi: 10.1128/AAC.02155-13. Epub 2013 Dec 23.

2.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
3.

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Marcos-Zambrano LJ, Escribano P, Sánchez C, Muñoz P, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2014 Aug;58(8):4565-72. doi: 10.1128/AAC.02670-14. Epub 2014 May 27. Erratum in: Antimicrob Agents Chemother. 2016 Jul;60(7):4430.

5.
6.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.

J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3.

PMID:
25473027
7.

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Pemán J, Cantón E, Linares-Sicilia MJ, Roselló EM, Borrell N, Ruiz-Pérez-de-Pipaon MT, Guinea J, García J, Porras A, García-Tapia AM, Pérez-Del-Molino L, Suárez A, Alcoba J, García-García I.

J Clin Microbiol. 2011 Dec;49(12):4158-63. doi: 10.1128/JCM.05474-11. Epub 2011 Oct 19.

8.

Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.

Jung SI, Shin JH, Song JH, Peck KR, Lee K, Kim MN, Chang HH, Moon CS; Korean Study Group for Candidemia.

Med Mycol. 2010 Jun;48(4):669-74. doi: 10.3109/13693780903410386.

PMID:
20392145
9.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
10.

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.

Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.

J Antimicrob Chemother. 2007 Aug;60(2):424-8. Epub 2007 Jun 11.

PMID:
17562683
11.

In vitro susceptibility of oral Candida to seven antifungal agents.

Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.

Oral Microbiol Immunol. 2005 Dec;20(6):349-53.

PMID:
16238594
12.

Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.

Samra Z, Yardeni M, Peled N, Bishara J.

Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):592-5.

PMID:
16172856
13.

In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia.

Flórez C, Martín-Mazuelos E, Ruiz M, Cisneros JM, Herrero M, García MV, Márquez M, Porras J, Martín P, Gamero C, Castón JJ; Grupo de Estudio de las Candidemias en Andalucía (Andalusian Study Group for Candidemia).

Enferm Infecc Microbiol Clin. 2009 Nov;27(9):518-22. doi: 10.1016/j.eimc.2008.09.013. Epub 2009 May 23. Erratum in: Enferm Infecc Microbiol Clin. 2010 Jun-Jul;28(6):405. García, Ma Victoria [corrected to García, M Victoria].

PMID:
19477048
14.

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).

Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):278-83. doi: 10.1016/j.diagmicrobio.2010.06.015. Epub 2010 Sep 16.

PMID:
20846808
15.

Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.

Mokaddas EM, Al-Sweih NA, Khan ZU.

J Med Microbiol. 2007 Feb;56(Pt 2):255-9.

PMID:
17244809
17.

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00906-17. doi: 10.1128/AAC.00906-17. Print 2017 Oct.

18.

In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.

Jang MJ, Shin JH, Lee WG, Kim MN, Lee K, Lee HS, Lee MK, Chang CL, Jang HC, Song ES, Kim SH, Shin MG, Suh SP, Ryang DW.

Ann Lab Med. 2013 May;33(3):167-73. doi: 10.3343/alm.2013.33.3.167. Epub 2013 Apr 17.

19.

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Krcmery V, Barnes AJ.

J Hosp Infect. 2002 Apr;50(4):243-60. Review.

PMID:
12014897
20.

Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.

Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M.

Med Mycol. 2003 Jun;41(3):235-9.

PMID:
12964715

Supplemental Content

Support Center